Dorzolamide Hydrochloride Size:Solid 10 mg Smiles: C[C@H](/C=C/[C@H](O)C1CC1)[C@H]1CC[C@H]2/C(/CCC[C@@]21C)=C/C=C1/C[C@@H](O)C[C@H](O)C/1=C

Smiles: C[C@H](/C=C/[C@H](O)C1CC1)[C@H]1CC[C@H]2/C(/CCC[C@@]21C)=C/C=C1/C[C@@H](O)C[C@H](O)C/1=C

CVT-313 is a promising candidate for evaluation in other disease models related to aberrant cell proliferation

MDV-3100for the treatment of castration-resistant prostate cancer

whereas the absence of P-gp causes a 6-fold increase in the plasma concentration and 3-fold higher brain-to-plasma concentration ratio after oral administration

Dorzolamide Hydrochloride Size:Solid 10 mg Smiles: C[C@H](/C=C/[C@H](O)C1CC1)[C@H]1CC[C@H]2/C(/CCC[C@@]21C)=C/C=C1/C[C@@H](O)C[C@H](O)C/1=CDorzolamide (trade name Trusopt) is a carbonic anhydrase inhibitor. It is an anti glaucoma agent and topically applied in the form of eye drops. This drug, developed by Merck, was the first drug in human therapy (market introduction 1995) which resulted from structure based drug design. Dorzolamide hydrochloride is used to lower increased intraocular pressure in open angle glaucoma and ocular hypertension. The combination of dorzolamide with timolol